Trial Profile
Investigation of local tolerability and efficacy of Muxan - a new topical treatment containing chloramine-T in 3 concentrations in comparison to Zovirax in patients with Herpes simplex type 1.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Jul 2023
Price :
$35
*
At a glance
- Drugs Chloramine-T (Primary) ; Aciclovir
- Indications Herpes labialis
- Focus Adverse reactions
- 03 Aug 2011 New trial record